Caroline Katherine Page

Ms. Caroline Katherine Page

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2024 in Viruses
Verified
Journal Article
Open access
PDF file
CPCaroline Katherine Page
Caroline Katherine Page
Stephen Mark TompkinsStephen Mark Tompkins
Stephen Mark Tompkins
Influenza A and influenza B viruses (FLUAV and FLUBV, respectively) cause significant respiratory disease, hospitalization, and mortality each year. Despite causing at least 25% of the annual disease burden, FLUBV is historically understudied. Unlike FLUAVs, which possess pandemic potential due to their many subtypes and broad host range, FLUBVs are thought to be restricted to only humans and are limited to two lineages. The hemagglutinins (HA) of both influenza types bind glycans terminating in α2,6- or α2,3-sialic acids. For FLUAV, the tropism of human- and avian-origin viruses is well-defined and determined by the terminal sialic acid configuration the HA can accommodate, with avian-origin viruses binding α2,3-linked sialic acids and human-origin viruses binding α2,6-linked sialic acids. In contrast, less is known about FLUBV receptor binding and its impact on host tropism. This review discusses the current literature on FLUBV receptor specificity, HA glycosylation, and their roles in virus tropism, evolution, and infection. While the focus is on findings in the past dozen years, it should be noted that the most current approaches for measuring virus–glycan interactions have not yet been applied to FLUBV and knowledge gaps remain.

28 March 2025 in Science Advances
Verified
Journal Article
Open access
CPCaroline Katherine Page
Caroline Katherine Page
JSJustin D. Shepard
Justin D. Shepard
SRSean D. Ray
Sean D. Ray
JFJames A. Ferguson
James A. Ferguson
ARAlesandra J. Rodriguez
Alesandra J. Rodriguez
Stephen Mark TompkinsStephen Mark Tompkins
Stephen Mark Tompkins
The two influenza B virus (FLUBV) lineages have continuously diverged from each other since the 1980s, with recent (post-2015) viruses exhibiting accelerated evolutionary rates. Emerging data from human studies and epidemiological models suggest that increased divergence in contemporary viruses may drive differential cross-protection, where infection with Yamagata lineage viruses provides limited immunity against Victoria lineage viruses. Here, we developed animal models to investigate the mechanisms behind asymmetric cross-protection between contemporary FLUBV lineages. Our results show that contemporary Victoria immunity provides robust cross-protection against the Yamagata lineage, whereas Yamagata immunity offers limited protection against the Victoria lineage. This differential cross-protection is driven by Victoria-elicited neuraminidase (NA)–specific antibodies, which show cross-lineage reactivity, unlike those from Yamagata infections. These findings identify a phenomenon in contemporary FLUBV that may help explain the recent disappearance of the Yamagata lineage from circulation, highlighting the crucial role of targeting NA in vaccination strategies to enhance cross-lineage FLUBV protection.

25 November 2025 in Journal of Virology
Verified
Journal Article
Open access
CPCaroline Katherine Page
Caroline Katherine Page
MMMHM Mubassir
MHM Mubassir
PCPradeep Chopra
Pradeep Chopra
LGLindsey Claire Gay
Lindsey Claire Gay
GGGinger Geiger
Ginger Geiger
Stephen Mark TompkinsStephen Mark Tompkins
Stephen Mark Tompkins
Receptor specificity plays a critical role in influenza virus host tropism and pathogenesis. Influenza A and influenza B viruses (FLUAVs and FLUBVs, respectively) utilize N-glycans with terminal sialic acids on glycoproteins decorating the surface of mucosal epithelial cells as receptors for the virus hemagglutinin (HA) protein. For FLUAVs, the specificity of HA binding to distinct sialic acid linkages on host glycans is a major determinant of species specificity. Amino acid motifs and N-linked glycosylation sites influencing FLUAV HA receptor specificity are well defined. In contrast, considerably less is known regarding determinants of FLUBV receptor specificity, despite its significant contribution to the global influenza disease burden and unique restriction for human hosts. To address this knowledge gap, we utilize microarrays populated with glycans resembling structures found in the respiratory tract to comprehensively define the receptor binding profiles of FLUBVs from different decades and lineages and confirm these results with complementary virus–glycan binding assays. Using wild-type and reverse genetics FLUBVs having singular mutations in the HA receptor binding site (RBS), as well as structural models, we identify an N-glycosylation site at amino acid 196 within the RBS that determines the breadth of HA binding to terminal sialic acids. The definition of the presence of an N-linked glycan as the primary determinant for FLUBV receptor specificity provides a clear mechanism for lineage-specific differences in HA receptor binding. This may help explain the distinct tropism observed between Victoria and Yamagata lineage FLUBVs and provide insights into the disappearance of the Yamagata lineage. IMPORTANCE: Influenza B viruses (FLUBVs) are a major cause of human respiratory disease, but the molecular determinants influencing receptor specificity for the hemagglutinin protein remain largely undefined. We defined the receptor specificity of a panel of Early, Victoria, and Yamagata lineage viruses spanning over 50 years and showed that Victoria lineage viruses can have expanded receptor specificity, compared to Yamagata lineage viruses. We identified a critical N-glycosylation site within the hemagglutinin that regulates hemagglutinin binding to sialic acid receptors on host cells. Recent successful subclades of the Victoria lineage viruses lost this glycosylation site, enabling binding to both human-type and avian-type sialic acid receptors, which may influence respiratory tract tropism. These viruses also showed increased endemic activity. The expanded receptor tropism of Victoria lineage viruses may have fitness benefits, helping to explain epidemiologic features of the lineage, perhaps contributing to the lineage’s recent success, while the Yamagata lineage appears to have become extinct.

20 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CPCaroline Katherine Page
Caroline Katherine Page
VZVictoria Zyulina
Victoria Zyulina
WZWuji Zhang
Wuji Zhang
GGGinger Geiger
Ginger Geiger
VDVrushali Dhamapurkar
Vrushali Dhamapurkar
Stephen Mark TompkinsStephen Mark Tompkins
Stephen Mark Tompkins
The two influenza B virus (FLUBV) lineages, Victoria and Yamagata, have continued to diverge since their separation in the 1970s, resulting in distinct antigenic characteristics and differences in immunity and cross-protection. Human epidemiological observations and experimental studies have identified lineage-specific differences in adaptive immune responses elicited by contemporary viruses, suggesting that innate immune signaling may contribute to these divergent outcomes. To understand in-depth immunity to contemporary influenza B viruses, we compared viral replication, cytokine production, gene expression, and cellular tropism following infection with representative Victoria- and Yamagata-lineage viruses. We found that, despite broadly similar cytokine profiles in the ferret upper respiratory tract, the two lineages exhibited distinct innate immune kinetics. Yamagata viruses induced rapid early expression of antiviral and inflammatory genes, including SOCS1 and multiple interferon-stimulated genes, whereas Victoria viruses displayed delayed innate immune activation accompanied by greater viral replication. Consistent with the ferret data, Yamagata viruses also induced elevated SOCS1 expression in human PBMCs early after infection. In addition, Yamagata viruses exhibited broader cellular tropism, infecting a wider range of immune cell populations than Victoria viruses. Together, these findings demonstrate that contemporary influenza B virus lineages distinctly engage the host immune system and provide new insight into how lineage-specific innate immune responses may contribute to differences in immunity, cross-protection, and the divergent evolutionary trajectories of Victoria and Yamagata viruses Author Summary: Influenza B viruses cause substantial seasonal disease, yet the biological differences between the Victoria and Yamagata lineages that may contribute to their distinct epidemiology and immune responses remain incompletely understood. Recent studies comparing lineage-specific immunity have focused primarily on adaptive responses, leaving differences in early host–virus interactions comparatively unexplored. Here, we show that representative Victoria and Yamagata viruses differ during the earliest stages of infection. Using ferret and human immune cell models, we found differences in how the viruses trigger antiviral defenses, how efficiently they replicate, and which immune cells they infect. These findings suggest that early interactions between influenza B viruses and the immune system may help shape the distinct immunity observed between the lineages. Understanding these differences provides new insight into influenza B virus biology and may help inform our understanding of viral evolution, immunity, and future influenza vaccine development.